In search of a miracle One of the toughest parts of my job is getting daily calls and emails from people desperate for a stem cell treatment or cure for themselves or a loved one and having to tell them that I don’t know of any. You can hear in their voice, read it in … Continue reading Headline: Stem Cell Roundup: Here are some stem cell stories that caught our eye this past week.
FDA
Early CIRM support helps stem cell pioneer develop promising new therapy for cancer
When you get praise from someone who has been elected to the National Academy of Sciences and has been named California Scientist of the Year you know you must be doing something right. That’s how we felt the other day when Irv Weissman, Director of the Stanford Institute of Stem Cell Biology and Regenerative Medicine, … Continue reading Early CIRM support helps stem cell pioneer develop promising new therapy for cancer
Overcoming one of the biggest challenges in stem cell research
Imagine you have just designed and built a new car. Everyone loves it. It’s sleek, fast, elegant, has plenty of cup holders. People want to buy it. The only problem is you haven’t built an assembly line to make enough of them to meet demand. Frustrating eh. Overcoming problems in manufacturing is not an issue … Continue reading Overcoming one of the biggest challenges in stem cell research
CIRM applauds FDA crackdown on stem cell clinics that “peddle unapproved treatments.”
CIRM is commending the US Food and Drug Administration (FDA) for its action against two stem cell clinics offering unapproved therapies. On Wednesday, the FDA filed two complaints in federal court seeking a permanent injunction against California Stem Cell Treatment Center Inc. and US Stem Cell Clinic LLC. of Sunrise, Florida. The FDA says the … Continue reading CIRM applauds FDA crackdown on stem cell clinics that “peddle unapproved treatments.”
If you’re into stem cell manufacturing, this is the conference for you!
Fulfilling CIRM’s mission doesn’t just mean accelerating promising stem cell treatments to patients. It also involves accelerating the whole field of regenerative medicine, which involves not just research, but developing candidate treatments, manufacturing cell therapies, and testing these therapies in clinical trials. Manufacturing and the pre-clinical safety evaluation of cell therapies are topics that don’t … Continue reading If you’re into stem cell manufacturing, this is the conference for you!
Breaking the isolation of rare diseases
How can something that affects 30 million Americans, one in ten people in the US, be called rare? But that’s the case with people who have a rare disease. There are around 7,000 different diseases that are categorized as rare because they affect fewer than 200,000 people. Less than five percent of these diseases have … Continue reading Breaking the isolation of rare diseases
Using the courts to protect patients from unapproved stem cell therapies
A recent article in Nature looked at using lawsuits to help rein in the activities of clinics offering "unapproved" therapies. CIRM's Geoff Lomax explains. When public health officials wanted to raise awareness about the dangers of smoking they filed lawsuits against the tobacco companies. They accused Big Tobacco of deceptive marketing and hiding the negative … Continue reading Using the courts to protect patients from unapproved stem cell therapies
Creating a platform to help transplanted stem cells survive after a heart attack
Repairing, even reversing, the damage caused by a heart attack is the Holy Grail of stem cell researchers. For years the Grail seemed out of reach because the cells that researchers transplanted into heart attack patients didn’t stick around long enough to do much good. Now researchers at Stanford may have found a way around … Continue reading Creating a platform to help transplanted stem cells survive after a heart attack
A year in review – CIRM’s 2017 Annual Report focuses on a year of accelerating stem cell treatments to patients
At CIRM we have our focus very clearly on the future, on accelerating stem cell therapies to patients with unmet medical needs. But every once in a while, it’s a good idea to look back at what you have already done. Knowing where you came from can help you get to where you are heading. … Continue reading A year in review – CIRM’s 2017 Annual Report focuses on a year of accelerating stem cell treatments to patients
Stories that caught our eye: How dying cells could help save lives; could modified blood stem cells reverse diabetes?; and FDA has good news for patients, bad news for rogue clinics
Growing up I loved watching old cowboy movies. Invariably the hero, even though mortally wounded, would manage to save the day and rescue the heroine and/or the town. Now it seems some stem cells perform the same function, dying in order to save the lives of others. Researchers at Kings College in London were trying … Continue reading Stories that caught our eye: How dying cells could help save lives; could modified blood stem cells reverse diabetes?; and FDA has good news for patients, bad news for rogue clinics
The Stem Cellar 